dr. kaufman on the side effect profiles of eribulin and capecitabine
Published 11 years ago • 3K plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
1:23
dr. kaufman discusses the use of eribulin in metastatic breast cancer
-
1:09
dr. vahdat discusses the side effects of halaven
-
1:37
dr. chris twelves compares eribulin and capecitabine
-
5:25
eribulin in metastatic breast cancer
-
1:38
dr. william gradishar discusses the eribulin and capecitabine 301 study
-
3:40
treatment with eribulin in metastatic breast cancer
-
6:06
combination of eribulin and capecitabine provides clinical benefit for women with mbc
-
4:41
dr. howard kaufman on the advancements of cancer immunotherapy
-
1:06
dr. vahdat on capecitabine and eribulin in advanced breast cancer
-
2:08
dr. joyce o'shaughnessy on eribulin in metastatic breast cancer
-
1:58
dr. twelves on a pooled analysis of eribulin in breast cancer
-
1:32
dr. gary schwartz on the survival benefit of eribulin in sarcoma
-
2:19
dr. twelves discusses eribulin for the treatment of breast cancer
-
2:13
dr. edith perez on study 301 that compared eribulin to capecitabine in mbc
-
4:12
eribulin in recurrent metastatic er breast cancer
-
2:01
dr. edith perez on a phase iii trial comparing eribulin and capecitabine
-
1:00
dr. mcintyre on eribulin as first-line therapy in her2- breast cancer
-
1:22
dr. brufsky on trastuzumab and eribulin for her2 metastatic breast cancer
-
9:49
patient selection for eribulin in breast cancer